ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

What Ails Us

Most genetic studies completely ignore the science of epigenetics, which is how the environment actually turns certain genes on or off.

FindCenter AddIcon

EXPLORE TOPIC

Psilocybin